{"groups":[{"description":"37.5 mg orally daily for 6-week cycle","id":"FG000","title":"Sunitinib"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"7"}],"type":"Lack of Response"},{"reasons":[{"groupId":"FG000","numSubjects":"4"}],"type":"Toxicities"},{"reasons":[{"groupId":"FG000","numSubjects":"3"}],"type":"Disease Progression"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"14"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"14"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"Recruitment Period: September 14, 2006 to December 17, 2007. All recruitment done at UT MD Anderson Cancer Center."}